PT-141 — bremelanotide — is the peptide guests choose for desire, arousal and confidence. Delivered privately to your villa, screened by a clinician first, and taught so you can continue at home. For women and men.
PT-141 (bremelanotide) is a synthetic peptide that works differently from anything in the Viagra family. Where those act on blood flow, PT-141 works centrally — it activates melanocortin receptors (chiefly MC4R) in the brain, the pathways involved in desire and arousal rather than plumbing. It is self-administered as a small subcutaneous injection, on-demand, ahead of intimacy.
It is worth being precise about its status, because PT-141 is unusual among peptides: it is genuinely FDA-approved. The branded product, Vyleesi, was approved in 2019 for acquired, generalised low sexual desire in premenopausal women. Use in men and in postmenopausal women is off-label — well-established and widely offered, but outside that specific label — and is provided here under physician supervision, screening-first, in a wellness context.
Common, well-documented effects include nausea (most often with the first dose, easing with use), a transient rise in blood pressure for a few hours, and occasional temporary skin darkening. It is not suitable for everyone — which is exactly why your clinician screens you before anything is dispensed or charged.
PT-141 is chosen by guests who want to reconnect with desire and confidence — and who value doing it privately, without a clinic waiting room or an awkward pharmacy counter.
Everything begins with a screen, not a sale. Before anything is dispensed, a clinician reviews your health history — blood pressure and cardiovascular status matter here — and confirms whether PT-141 is right for you. Not every guest is a candidate, and we will tell you so honestly. Your card is only held during booking; you are charged once your clinician confirms.
If you proceed, a clinician comes to your villa, reconstitutes your PT-141 with you, and teaches you to draw, dose and self-inject — supervising your first dose so you leave genuinely able to run it yourself. You go home with a discreet take-home kit, a personalised dosing card in plain language, and a compliant remote re-supply path through a licensed telehealth partner, so the protocol continues without interruption.
Reserve in two minutes. Your card is only held — a clinician reviews your details and screens you first; you’re charged only once your protocol is confirmed.
Most places hand you a vial and wave goodbye. We do the opposite: PT-141 here is physician-screened first, lab-verified (every vial carries a Certificate of Analysis you can read), and taught rather than merely sold — delivered with total discretion to your villa, and supported long after you fly home.
PT-141, also called bremelanotide, is a peptide that supports sexual desire and arousal by acting on melanocortin receptors in the brain — a central pathway, unlike Viagra-type medications that work on blood flow. It is self-administered as a small on-demand injection. At SEVA it is offered in-villa, only after a physician screens you.
Yes and no, and it is worth being honest about it. PT-141 is FDA-approved as the branded product Vyleesi (2019) for premenopausal women with acquired, generalised low desire. Use in men and postmenopausal women is off-label — common and well-understood, but outside that specific approval — and is provided here under medical supervision after individual screening. It is not suitable for everyone.
Guests of both sexes choose it. The FDA approval is specific to premenopausal women; use by men is off-label. Because it acts on desire centrally rather than on blood flow, some choose it as a different approach from PDE5 options like Viagra. Your clinician will discuss whether it fits you during your screen.
It is designed to be taken on-demand ahead of intimacy rather than daily. Individual experiences vary, which is one reason the protocol is personalised to you and taught hands-on so your timing and dose are dialled in. Your clinician covers exact timing on your dosing card.
The most common effect is nausea, usually with the first dose and easing with use; some people notice a short-lived rise in blood pressure or temporary skin darkening. It is not appropriate for people with uncontrolled high blood pressure or known cardiovascular disease — which is precisely why every guest is screened first and not everyone is a candidate. Individual results vary; this is a physician-supervised wellness service, not a treatment for any disease.
Yes. We teach you to self-administer during your stay and set you up with a discreet take-home kit, a personalised dosing card, and a compliant re-supply path through a licensed telehealth partner in your country — so nothing stops when the trip does. Pair it with our peptide protocols if you like.
Seva Vitality provides wellness and optimization services in a private, physician-supervised setting. It is not intended to diagnose, treat, cure or prevent any disease; a health screen applies and not all treatments suit everyone. Peptide and GLP-1 therapies described here are physician-led and, where applicable, not FDA-approved and offered in a wellness & research context under medical supervision.